前列腺特异性抗原 doubling time（PSADT）对高复发前列腺癌治疗决策至关重要，但临床实践中PSADT文档率低（37%）。本研究显示，PSADT文档患者较文档缺失者治疗启动更早（中位数1.0 vs 6.7个月），但医生常高估PSADT低估疾病进展风险。 几乎一半的前列腺癌患者在根治 ...

NEW YORK (Reuters Health) - A diet low in saturated fat, high in vegetable protein and low in animal protein, including dairy products, is associated with a "substantial" increase in prostate-specific ...

We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event ...

Many patients with high-risk biochemically recurrent prostate cancer based on PSA doubling time are unidentified in clinical practice. Clinicians unaware of patients’ PSA doubling time (PSADT) at ...

PSADT is vital for monitoring prostate cancer recurrence and guiding treatment decisions, yet often inaccurately calculated by physicians. Inconsistent PSADT documentation can lead to treatment delays ...

Men with rising PSA following initial therapy for localized prostate cancer experienced an increase in PSA doubling time (PSADT) after being treated with pomegranate extract, according to a new study.

A 1-year period of intensified androgen receptor blockade prolonged prostate-specific antigen progression-free survival (PSA-PFS) compared with androgen deprivation therapy (ADT) alone for patients ...